Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window

 Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st April, 2021 and will be re-opened 48 hours after the submission of the Audited Financial Results for the Financial Year ended 31st March, 2021 to the Stock Exchanges.
26-03-2021
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Acquisition

 We would like to inform you that the Company has subscribed to partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP). The disclosure pursuant to Regulation 30 of the Listing Regulations and Clause A(1) of Part A, Schedule III of the Listing Regulations, is attached as per 'Annexure I'. The above is for your information and record.
25-03-2021
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificates
20-03-2021
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
03-03-2021
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Issue of Duplicate Share Certificates
24-02-2021
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
16-02-2021

Hold Torrent Pharmaceuticals: target of Rs 3100: Sharekhan

 Sharekhan recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1800 in its research report dated February 08, 2021.
11-02-2021
Bigul

Broker's call: Torrent Pharma (Buy)

 Anand Rathi Torrent Pharma (Buy)Target: 3,195CMP: 2,593.05Impacted by product discontinuation in its US business and the lockdown in LATAM, Torrent
10-02-2021
Bigul

Weak US outlook in near term, higher costs to weigh on Torrent Pharma

 While the stock has corrected, valuations leave little room for upside
09-02-2021
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificates
09-02-2021
Next Page
Close

Let's Open Free Demat Account